{
    "general_params": {
        "compounds": [
            {
                "pubchem_id": 2019,
                "compound": "actinomycin",
                "mol_mass": 1254.628,
                "molecular_formula": "C62H86N12O16",
                "chem_struct": "CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C",
                "chem_synonyms": [
                    "actinomycin D",
                    "Actinomycin Aiv",
                    "Actinomycin I",
                    "Dactinomycin D",
                    "Oncostatin K",
                    "Chounghwamycin B",
                    "Actinomycin 7",
                    "Actinomycin I1",
                    "Actinomycin X 1",
                    "Actinomycin A IV",
                    "Acto-D",
                    "Actinomycin 11 cosmegen",
                    "Actinomycin IV",
                    "Actinomycin C1",
                    "Dilactone actinomycin D acid",
                    "50-76-0",
                    "Dilactone actinomycindioic D acid",
                    "Meractinomycin",
                    "Cosmegen",
                    "Actinomycin I(sub 1)",
                    "Lyovac cosmegen",
                    "Antibiotic from Streptomyces parvullus",
                    "Actinomycindioic D acid, dilactone",
                    "Actinomycin-(threo-val-pro-sar-meval)",
                    "HBF 386 meractinomycin",
                    "CCRIS 9",
                    "Actinomycin C(sub1)",
                    "ACT D",
                    "HSDB 3220",
                    "Actactinomycin A IV",
                    "Dactinomycine [INN-French]",
                    "Dactinomycinum [INN-Latin]",
                    "Dactinomicina [INN-Spanish]",
                    "HBF 386",
                    "AD (VAN)",
                    "Actinomycin-[threo-val-pro-sar-meval]",
                    "X 97",
                    "Actinomycin X1",
                    "GNF-PF-1977",
                    "actinomycin cl",
                    "dactinomyein d",
                    "NCI-C04682",
                    "NSC 3053",
                    "actinomycin x i",
                    "D Actinomycin",
                    "EINECS 200-063-6",
                    "Dactinomycin [USAN:BAN]",
                    "AI3-26374",
                    "(-)-actinomycin d",
                    "Dactinomycin (USP)",
                    "COSMEGEN (TN)",
                    "NSC3053",
                    "actinomyein-theo-val-pro-sar-meval",
                    "Dilactone actin omycindioic D acid",
                    "3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-",
                    "Specific stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)-bis(carbonylimino(2-hydroxypropylidene)carbonyliminoisobutylidenecarbonyl-1,2-pyrrolidinediylcarbonyl(methylimino)methylenecarbonyl))bis(N-methyl-L-valine) dilactone",
                    "Stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis(carbonylimino(2-(1-hydroxyethyl)-1-oxo-2,1-ethanediyl)imino(2-(1-methylethyl)-1-oxo-2,1-ethanediyl)-1,2-pyrrolidinediylcarbonyl(methylimino) (1-oxo-2,1-ethanediyl)))bis(N-methyl-L-valine)di-xi-lactone",
                    "Actinomycin C(1)",
                    "C62H86N12O16",
                    "(- )-actinomycin d",
                    "l-3-oxo-",
                    "AC1L1CQX",
                    "Actinomycin D (JP17)",
                    "Actinomycin D deriv. of 3H-phenoxaocardazine",
                    "ACTINOMYCIN D  AMP",
                    "Neuro_000003",
                    "SCHEMBL6152",
                    "CBiol_002056",
                    "Actinomycin D, sodium deoxyribonucleic acid complex",
                    "o)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine",
                    "4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide",
                    "CHEMBL427947",
                    "MEGxm0_000350",
                    "ACon0_000471",
                    "ACon1_001004",
                    "Actinomycindioic D acid dilactone",
                    "BCBcMAP01_000155",
                    "CHEBI:125400",
                    "RJURFGZVJUQBHK-UHFFFAOYSA-N",
                    "Bio1_000342",
                    "Bio1_000831",
                    "Bio1_001320",
                    "HMS3267F05",
                    "HMS3394O17",
                    "1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine",
                    "2-amino-4,6-dimethyl-3-oxo-N,N'-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide",
                    "C1",
                    "LMPK14000005",
                    "LS-142",
                    "NSC191297",
                    "NSC684906",
                    "AKOS024456475",
                    "NSC-191297",
                    "NSC-684906",
                    "RL03866",
                    "SMP1_000005",
                    "NCGC00025059-02",
                    "NCGC00025059-03",
                    "NCGC00025059-04",
                    "NCGC00169767-01",
                    "AN-41578",
                    "NCI60_030539",
                    "FT-0602272",
                    "C06770",
                    "D00214",
                    "BRD-A42383464-001-02-2",
                    "BRD-A42383464-001-05-5",
                    "Actinomycin D deriv. of 1H-pyrrolo(2,1-1)(1,4,7,10,13)oxatetra-azacyclohexadecine",
                    "10,10'-[(2-Amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-Diyl)bis(carbonylimino)]bis-[dodecahydro-6,13-diisopropyl-2,5,9-trimethyl-1H-Pyrrolo-(2,1-1)(1,4,7,10,13)oxatetra-azacyclohexadecine]-1,4,7,11,14",
                    "2-Amino-(N,N)-1-bis(hexadecahydro-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1]-[1,4,7,10,13] oxatetraazacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide",
                    "2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",
                    "2-Amino-N,N'-bis-[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-1)(1,4,7,10,13)oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarb",
                    "2-amino-N,N'-bis[(6S,9R,10S,13R,18aS)-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide",
                    "2-Amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide",
                    "2-Amino-N,N'-bis[hexadecahydro-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-1)(1,4,10,13)oxatetraazacyclohexadecin-10-yl]-",
                    "2-amino-N1,N9-bis(3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl)-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide",
                    "3H-phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethy",
                    "3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethy l-3-oxo-",
                    "3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis[hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-4,6-dimethyl-3-oxo-",
                    "Bis(XI-lactone)N,N'-[(2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis-[carbonylimino(3-hydroxy-1-oxobutylidene)imino(3-methyl-1-oxobutylidene)(tetrahydro-1H-pyrrole-1,2-diyl)carbonyl(methylimin",
                    "NCGC00025059-05!2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide",
                    ""
                ]
            }
        ],
        "loci": {
            "accession": "HM038106.1",
            "conn_comp_cluster": [
                "Unknown"
            ],
            "complete": "Unknown"
        },
        "mibig_accession": "BGC0000296",
        "publications": [
            "pubmed:10212227",
            "pubmed:10780924",
            "pubmed:20304989"
        ],
        "minimal": true,
        "biosyn_class": [
            "NRP"
        ]
    },
    "personal": {
        "submitter_name": "mibig.secondarymetabolites.org",
        "submitter_institution": "MIBiG",
        "submitter_email": "info@mibig.secondarymetabolites.org"
    },
    "changelogs": [
        {
            "version": "2.0",
            "comment": "Submitted"
        }
    ]
}